Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Trial of OSI-461 in CLL
NCT00073489Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- May 2001
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of CP-461 in chronic lymphocytic leukemia (CLL), sponsored by Astellas Pharma. Primary endpoint: Activity of OSI-461. Started May 2001; status: completed.
02
Drugs
CP-461
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00073489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073489.